Consistent with this observation, increased serum levels of soluble NOX2-derived peptides and NOX2-generated oxidative stress have been found to be associated with the severity of liver steatosis in MASLD patients [95]. Here, CYBB is linked to metabolic dysfunction-associated steatotic liver disease.